# Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension

> **NCT00945958** · PHASE3 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 161 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** SPARC0913

## Key facts

- **NCT ID:** NCT00945958
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945958, "Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00945958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*